COVID-19 vaccine to enter human phase by late Feb.: Official

Tehran (IP) - Director of the Scientific Commission in Iran's National Headquarters for Combating the Coronavirus said that coronavirus vaccine produced by seven knowledge-based companies will enter the human phase by the end of February.

Iran PressIran news: In an interview with Mehr News Agency on Monday, Mostafa Ghanei said that seven companies producing the COVID-19 vaccine are running under the strict supervision of the Biotechnology Development Headquarters of the Vice-Presidency for Science and Technology.

"Of total seven knowledge-based companies, COVID-19 vaccine produced by three of them will enter the human phase," he said, adding: “It is hoped that these knowledge-based companies will receive the license.”

"Of three companies entering the clinical phase of the vaccine, one company has made significant progress, and will start clinical trials sooner than the other companies," he added.

Elsewhere in his remarks, Ghanei said that four other research groups will receive the license for conducting clinical trials from the Iranian Food and Drug Administration (IFDA).

"In general, seven knowledge-based companies will receive the clinical licenses at the support of Biotechnology Development Headquarters by February," he added.


Read more:

Iran trying to make, buy vaccine but the US sabotages it: Rouhani

27,000 people volunteer for Iranian COVID vaccine